These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 7542074)
1. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Dvorak HF; Detmar M; Claffey KP; Nagy JA; van de Water L; Senger DR Int Arch Allergy Immunol; 1995; 107(1-3):233-5. PubMed ID: 7542074 [TBL] [Abstract][Full Text] [Related]
2. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF EXS; 1997; 79():233-69. PubMed ID: 9002222 [TBL] [Abstract][Full Text] [Related]
4. Role of VEGF-flt receptor system in normal and tumor angiogenesis. Shibuya M Adv Cancer Res; 1995; 67():281-316. PubMed ID: 8571818 [No Abstract] [Full Text] [Related]
5. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. Brown LF; Olbricht SM; Berse B; Jackman RW; Matsueda G; Tognazzi KA; Manseau EJ; Dvorak HF; Van de Water L J Immunol; 1995 Mar; 154(6):2801-7. PubMed ID: 7876550 [TBL] [Abstract][Full Text] [Related]
7. The role of vascular endothelial growth factor in angiogenesis. Ferrara N; Gerber HP Acta Haematol; 2001; 106(4):148-56. PubMed ID: 11815711 [TBL] [Abstract][Full Text] [Related]
8. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis. Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073 [TBL] [Abstract][Full Text] [Related]
9. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Brown LF; Tognazzi K; Dvorak HF; Harrist TJ Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848 [TBL] [Abstract][Full Text] [Related]
10. Vascular permeability factor (VPF, VEGF) in tumor biology. Senger DR; Van de Water L; Brown LF; Nagy JA; Yeo KT; Yeo TK; Berse B; Jackman RW; Dvorak AM; Dvorak HF Cancer Metastasis Rev; 1993 Sep; 12(3-4):303-24. PubMed ID: 8281615 [TBL] [Abstract][Full Text] [Related]
11. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. Detmar M; Brown LF; Berse B; Jackman RW; Elicker BM; Dvorak HF; Claffey KP J Invest Dermatol; 1997 Mar; 108(3):263-8. PubMed ID: 9036922 [TBL] [Abstract][Full Text] [Related]
13. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor. Brown LF; Detmar M; Tognazzi K; Abu-Jawdeh G; Iruela-Arispe ML Lab Invest; 1997 Feb; 76(2):245-55. PubMed ID: 9042161 [TBL] [Abstract][Full Text] [Related]
14. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Dvorak HF; Nagy JA; Feng D; Brown LF; Dvorak AM Curr Top Microbiol Immunol; 1999; 237():97-132. PubMed ID: 9893348 [TBL] [Abstract][Full Text] [Related]
15. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193 [TBL] [Abstract][Full Text] [Related]
16. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592 [TBL] [Abstract][Full Text] [Related]
19. Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints. Matsumoto Y; Tanaka K; Hirata G; Hanada M; Matsuda S; Shuto T; Iwamoto Y J Immunol; 2002 Jun; 168(11):5824-31. PubMed ID: 12023386 [TBL] [Abstract][Full Text] [Related]
20. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway. Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]